Treatment of idiopathic pulmonary fibrosis: The rise and fall of corticosteroids

American Journal of Medicine

Volumn 110, Issue 4, 2001, Pages 326-328

  Collard, Harold R ^a,b   King Jr , Talmadge E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EDITORIAL; LUNG FIBROSIS; LUNG TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE;

ADRENAL CORTEX HORMONES; APOPTOSIS; HUMANS; INFLAMMATION; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035126575     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00622-2     Document Type: Editorial

References (15)

1. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement
2. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future
3. Steroids in idiopathic pulmonary fibrosis: A prospective assessment of adverse reactions, response to therapy, and survival
4. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis
5. Idiopathic pulmonary fibrosis: Progress in understanding its pathogenesis and implications for therapy
6. NSIP, UIP, and the ABCs of idiopathic interstitial pneumonias
7. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification
8. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
9. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis
10. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns: Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia
11. Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP
12. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis
13. Natural history and treated course of usual and desquamative interstitial pneumonia
14. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: Results of a prospective, open-label phase II study
15. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis